3 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Alectinib versus ... Non–Small-Cell Lung Cancer #EBM ... #Honc #Alectinib ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... #Cardiology #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
and Cardiogenic Shock ... #EBM #Cardiology ... #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM